Intelligence in Medical Technologies

What Intelligence in Medical Technologies does

Intelligence in Medical Technologies (IMT) is a privately held French medical software company that develops vascular medical imaging analysis software focused on Intima Media Thickness (IMT) measurement, plaque detection, and stenosis quantification from ultrasound images and video sequences. The company's two core products are M'AthCloud, a HIPAA-compliant cloud-based SaaS platform distributed at www.ipsocloud.com for physicians and clinical trial operators, and M'Ath, a Windows-based desktop application available in M'Ath Std and M'AthSR versions and supporting French, English, Italian, Spanish, and Portuguese languages. Both products generate examination reports with reference values adjusted for age, sex, and country, and are positioned for primordial prevention and 5P medicine targeting undiagnosed cardiovascular risk factors in patients aged 40-60.

IMT generates revenue through three streams: credit-based subscriptions on M'AthCloud, one-time/perpetual licenses for the M'Ath desktop software, and project-based professional services delivered through its Corelab activities — which include sonographer certification, investigator training, site setup, and centralized expert reading/re-reading for multi-center clinical trials and epidemiological studies. Its customer base is organized around three segments: Contract Research Organizations conducting multi-center vascular trials, hospitals and large medical centers running epidemiological and interventional studies, and individual physicians performing arterial health examinations. The company holds FDA 510(k) clearance and CE Mark for its vascular medical imaging software, enabling commercial distribution in both European and North American markets, and maintains a headquarters in Paris with a North American regional office in Miami.

The company was founded by Pr Pierre-Jean Touboul, Professor of Vascular Neurology at Bichat Hospital in Paris, who has published over 90 articles on atherosclerosis evaluation and stroke. Current CEO Alain de Thomasson, formerly VP Customer Services at Evernex and Services Sales Director at Nokia, leads international business development. IMT cites 10+ years of participation in large epidemiological and interventional drug studies, with cumulative activity spanning more than 600 operating centers, 25,000+ patients, 50,000+ expert readings, and 400+ certified sonographers across European, American, and Asian countries. No external funding rounds, institutional investors, or parent company affiliations are disclosed in source materials.

Name

Intelligence in Medical Technologies

Legal name

Intelligence In Medical Technologies

Website

https://iimt.fr

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Intelligence in Medical Technologies is a privately held French medical software company that develops vascular imaging analysis tools (M'AthCloud SaaS and M'Ath desktop software) for measuring intima media thickness, plaque, and stenosis. It serves CROs, hospitals, and physicians running clinical trials and cardiovascular risk assessments across Europe and North America.

Ownership category

akta.pro rank

Product category

Vascular Medical Imaging Software

NAICS

Software Publishers (513210), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Medical Imaging AI (HDAAAEAH)

akta.pro secondary industry

Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE)

Keywords

• Vascular imaging software
• Medical imaging analysis
• Arterial health assessment
• Clinical trial services
• Ultrasound image processing

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. M'AthCloud SaaS Subscription: Subscription-based cloud software accessed via www.ipsocloud.com. Users purchase credits for study measurements after completing registration and training.
2. M'Ath Software License: Windows desktop software sold as M'Ath® Std and M'Ath®SR versions. Software runs on Windows 8 and 10.
3. Professional Services: Sonographer certification (training sessions and test patient validation), investigator training (M'AthCloud half-day, M'AthStd 2-3 hours), and expert reading/rereading activities for clinical trials.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Intelligence in Medical Technologies develops and sells vascular medical imaging software — M'AthCloud© (HIPAA-compliant cloud-based SaaS) and M'Ath© (Windows desktop) — that quantify intima-media thickness, plaque, and stenosis from ultrasound images and videos for arterial health assessment. The company also provides clinical trial Corelab services, including sonographer certification, investigator training, and centralized expert reading, for CROs, hospitals, and large medical centers running vascular clinical studies.

Product overview

Intelligence in Medical Technologies offers two core medical imaging software products: M'AthCloud© (a cloud-based SaaS platform accessible via web browser) and M'Ath© (a Windows-based desktop software). Both products are dedicated to vascular imaging analysis, specifically measuring intima-media thickness (IMT), plaque, and stenosis from ultrasound images and video sequences. The company also provides clinical trial services including sonographer certification, investigator training, and centralized expert reading activities for epidemiological and interventional studies.

Differentiator

Problem solved

Functional benefit

Brands

• M'AthCloud©: Web-based SaaS application for arterial health examination and clinical trials data acquisition, measurement, and management. Available at www.ipsocloud.com. HIPAA compliant cloud solution for vascular imaging analysis.
• M'Ath©

Products and services

• M'AthCloud© HIPAA-compliant cloud-based SaaS platform for arterial health examination and clinical trials data acquisition. Enables web-based measurement of intima-media thickness, plaque thickness, and plaque area from ultrasound images and videos, with automated generation of examination reports incorporating age-, sex-, and country-adjusted reference values. Users purchase credits for study measurements after registration and training.
• M'Ath© Windows desktop software (M'AthStd and M'AthSR versions) for IMT, plaque thickness, and stenosis degree measurement on images from any ultrasound device. Provides real-time measurement capability on video sequences for distensibility and arterial stiffness assessment. Runs on Windows 8 and 10; supports French, English, Italian, Spanish, and Portuguese. Sold via direct sales for use by physicians, hospitals, and large medical centers.
• Corelab Activities for Clinical Trials Centralized reading services for clinical trials and epidemiological studies, covering sonographer certification (training sessions and test-patient validation), investigator training (M'AthCloud half-day, M'AthStd 2-3 hours), site setup, operations follow-up, and data collection management, plus expert reading/rereading activities. Delivered for CROs, hospitals, and pharmaceutical studies, with experience spanning European, American, and Asian countries and over 400 certified sonographers.

Quantifiable outcome

• 20-50% of population has undiagnosed atherosclerosis risk factors detectable through IMT measurement
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Arterys: AI-powered medical imaging platform with deep roots in cardiac MRI/CT analysis (acquired by Tempus). Comparable as an emerging cardiac/vascular imaging AI platform that overlaps with IMT's clinical-trial imaging analytics focus.
• Quibim: Spanish medical imaging AI platform providing quantitative imaging biomarkers for clinical trials and hospital use. Comparable as an emerging AI imaging analytics vendor serving pharma trial sponsors, a similar go-to-market as IMT.
• HeartVista: Cardiac MRI automated acquisition and analysis vendor. Comparable as a specialty cardiovascular imaging AI player operating in the clinical trial and clinical measurement space that intersects with IMT's vascular analytics niche.
• Us2.ai: Singapore-based AI company providing fully automated echocardiography analysis. Comparable as an emerging cardiac ultrasound AI vendor serving hospital and clinical trial use cases similar to IMT's target market.

Broad incumbents

• Philips HealthSuite / IntelliSpace Portal: Global incumbent medical imaging and informatics vendor with TomTec-based cardiovascular quantification within IntelliSpace Portal. Overlaps with IMT in vascular ultrasound measurement and enterprise imaging workflows.
• GE HealthCare: Global incumbent in ultrasound (Vivid) and imaging IT (Edison). Comparable through EchoPAC/AI-driven vascular and cardiac quantification that competes with IMT in trial and clinical measurement workloads.
• Siemens Healthineers (syngo.via): Global incumbent with syngo.via cardiovascular imaging post-processing. Comparable as a broad imaging software portfolio that competes with specialist vascular analytics vendors like IMT in hospital trials and clinical workflows.

Direct peers

• Circle Cardiovascular Imaging: Canadian cardiovascular MR/CT imaging analysis software vendor used in clinical trials and clinical reporting. Directly comparable for quantitative cardiac and vascular imaging analysis sold to hospitals and research institutions.
• Pie Medical Imaging: Netherlands-based cardiovascular imaging analysis company (now part of Philips) specializing in 2D/3D cardiac and vascular quantification. Directly comparable to IMT's IMT/plaque quantification focus on ultrasound images.
• Medis Medical Imaging Systems: Dutch cardiovascular imaging analysis software vendor offering quantitative tools for vessel and IMT analysis. Directly comparable to IMT for vascular ultrasound quantification used in clinical trials and clinical practice.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/8388325

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelligence in Medical Technologies